EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein

Yuchun Wang, Gang Yang, Xinyu Zhang, Ruoling Bai, Deyu Yuan, Denghui Gao, Qianyu He, Yi Yuan, Xinghe Zhang, Junchuang Kou, Lihua Zheng, Yanxin Huang und 4 weitere

Advanced Science · 2024-07 · 11 (26)

DOI: 10.1002/advs.202309639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 29.04.2024. Verfasst von Yuchun Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Laboratory for Druggable Gene and Protein Screening, College of Life Science, Northeast Normal University, Changchun, 130024, P.…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Aptamers, Nucleotide, Proteolysis. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Sichuan Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting “undruggable” targets with intrinsically disordered structures is of great significance for the treatment of disease. The transcription factor c‐Myc controls global gene expression and is an attractive therapeutic target for multiple types of cancers. However, due to the lack of defined ligand binding pockets, targeted c‐Myc have thus far been unsuccessful. Herein, to address the dilemma of lacking ligands, an efficient and high throughput aptamer screening strategy is established, named polystyrene microwell plate‐based systematic evolution of ligands by exponential enrichment (microwell‐SELEX), and identify the specific aptamer (MA9C1) against c‐Myc. The multifunctional aptamer‐based Proteolysis Targeting Chimeras (PROTAC) for proteolysis of the c‐Myc (ProMyc) is developed using the aptamer MA9C1 as the ligand. ProMyc not only significantly degrades c‐Myc by the ubiquitin‐proteasome system, but also reduces the Max protein, synergistically inhibiting c‐Myc transcriptional activity. Combination of the artificial cyclization and anti‐PD‐L1 aptamer (PA1)‐based delivery system, circular PA1‐ProMyc chimeras achieve tumor regression in the xenograft tumor model, laying a solid foundation for the development of efficacious c‐Myc degrader for the clinic. Therefore, this aptamer‐based degrader provides an invaluable potential degrader in drug discovery and anti‐tumor therapy, offering a promising degrader to overcome the challenge of targeting intractable targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycAptamers, NucleotideProteolysisHumansAnimalsMiceCell Line, TumorDisease Models, AnimalSELEX Aptamer TechniqueAntineoplastic Agents

Stichwörter der Autor:innen

aptamer‐based PROTACc‐Myc aptamerc‐Myc degradationmicrowell‐SELEXundruggable

Substanzen

Proto-Oncogene Proteins c-mycAptamers, NucleotideAntineoplastic AgentsMYC protein, human

Autor:innen und Institutionen

  • National Engineering Laboratory for Druggable Gene and Protein Screening, College of Life Science, Northeast Normal University, Changchun, 130024, P. R. China.
  • College of Life Science, Sichuan University, Chengdu, Sichuan, 610064, P. R. China.
  • Natural Products Research Centre, Chengdu Institution of Biology, Chinese Academy of Science, Chengdu, 610041, P. R. China.
  • lncTAC Bio., Chengdu, Sichuan, 610200, P. R. China.

ORCID-Profile: Yongyun Zhao

Förderung

  • Science and Technology Program of Sichuan Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wang, Y., Yang, G., Zhang, X., Bai, R., Yuan, D., Gao, D., He, Q., Yuan, Y., Zhang, X., Kou, J., Zheng, L., Huang, Y., Tang, Z., Bao, Y., Song, X., & Zhao, Y. (2024). Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein. Advanced Science, 11(26). https://doi.org/10.1002/advs.202309639

Vancouver

Wang Y, Yang G, Zhang X, Bai R, Yuan D, Gao D, et al. Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein. Advanced Science. 2024;11(26). doi:10.1002/advs.202309639

BibTeX
@article{Wang2024,
  author = {Wang, Yuchun and Yang, Gang and Zhang, Xinyu and Bai, Ruoling and Yuan, Deyu and Gao, Denghui and He, Qianyu and Yuan, Yi and Zhang, Xinghe and Kou, Junchuang and Zheng, Lihua and Huang, Yanxin and Tang, Zhuo and Bao, Yongli and Song, Xu and Zhao, Yongyun},
  title = {Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {26},
  doi = {10.1002/advs.202309639}
}
Kostenlos starten →